In the 800-mg cohort, two patients experienced a DLT: One developed a combination of a grade 3 increase in ALT and AST, and one developed a grade 3 hepatobiliary disorder (bile duct obstruction). This evidence concerns the gene GPT and Biliary tract obstruction.